A detailed history of Sherbrooke Park Advisers LLC transactions in Iradimed Corp stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 7,516 shares of IRMD stock, worth $410,749. This represents 0.09% of its overall portfolio holdings.

Number of Shares
7,516
Previous 4,741 58.53%
Holding current value
$410,749
Previous $208 Million 81.44%
% of portfolio
0.09%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$43.23 - $50.29 $119,963 - $139,554
2,775 Added 58.53%
7,516 $378 Million
Q2 2024

Aug 14, 2024

BUY
$40.36 - $44.7 $191,346 - $211,922
4,741 New
4,741 $208 Million

Others Institutions Holding IRMD

About IRADIMED CORP


  • Ticker IRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,565,100
  • Market Cap $687M
  • Description
  • IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...
More about IRMD
Track This Portfolio

Track Sherbrooke Park Advisers LLC Portfolio

Follow Sherbrooke Park Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherbrooke Park Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sherbrooke Park Advisers LLC with notifications on news.